Abstract 4365029: Temporal Association and Prognosis of Atrial Fibrillation/Flutter with Heart Failure and its Subtypes in Post-menopausal Women: A Women’s Health Initiative Study
Abstract
Introduction: Heart failure (HF) and atrial fibrillation/flutter (AF) often co-occur in older adults. Understanding the temporal relationship of HF and its subtypes (HFpEF and HFrEF) with AF and their prognosis are understudied and was the objective herein. Methods: This prospective cohort study included 31,171 post-menopausal women from the Women’s Health Initiative (WHI) study with adjudicated HF outcomes, merged with Medicare database for adjudicated AF outcomes during a median follow-up of 17 years. Participants were categorized into 4 groups: No incident AF or HF (n=22578); incident AF (n=6466); incident HF (n=1004); and both incident AF-HF (n=1123). Cox proportional hazards regression analysis was performed to study temporal association between AF and HF, all-cause and cardiovascular death (CVD). Results: Participants had a mean age of 63.2 (6.9) years at baseline. The risk of all-cause and CVD related death was elevated in incident AF [all-cause death HR 95% CI: 1.15 (1.08, 1.21); CVD death HR 95% CI: 1.32 (1.17, 1.50)], incident HF [All-cause death HR 95% CI: 1.84 (1.69, 2.01); CVD death HR 95% CI: 3.43 (2.94, 4.00)], and incident AF-HF [All-cause death HR 95% CI: 1.72 (1.59, 1.87); CVD death HR 95% CI: 3.57 (3.12, 4.10)] compared to no AF or HF. Risk of developing incident HFpEF [HR, 95% CI: 2.03 (1.77, 2.32)] and incident HFrEF [HR, 95% CI 1.33 (1.12, 1.59)] was higher with prior AF development compared to no prior AF. Conclusion: All-cause and CVD mortality is elevated with development of new AF, however mortality is much higher with incident HF or HF co-occurrence with AF. Risk of both HFpEF and HFrEF is elevated with presence of AF, with risk much higher for HFpEF in post-menopausal women. These findings underscore the importance of early detection and treatment of AF in post-menopausal women which can help reduce HF incidence and thereby overall mortality.
Article Details
Authors (9)
Muhammad Baig
Brown University, Providence, Rhode Island, United States
Muhammad Zain Ali
Brown University, Providence, Rhode Island, United States
Michael LaMonte
University at Buffalo - SUNY, Buffalo, New York, United States
Ali Khan
Mary Roberts
Care New England Medical Group, Pawtucket, Rhode Island, United States
Miremad Moafi-Madani
Brown University School of Public Health, Providence, Rhode Island, United States
Joseph Larson
Fred Hutch Cancer Center, Seattle, Washington, United States
Nishant Shah
Duke University Medical Center, Cary, North Carolina, United States
Charles Eaton
Harvard University, Cambridge, MA, USA.